Sinil Pharmaceutical Co. Ltd

012790 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

6,540.00KRW+140.00 (+2.19%)

Price History

Full chart

Market Stats

Previous Close6,400.00

Open6,370.00

Day Range6,370.00 – 6,580.00

52-Week Range4,820.00 – 6,612.67

Volume28.43K

Market Cap74.91B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield2.95%

Beta0.50

50-Day Avg5,821.80

200-Day Avg5,826.40

About

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Mi-Keun Jung
Employees0
Headquarters28, Boksanggol-gil, Chungju-si, South Korea, Korea
Websitehttps://www.sinilpharm.com

Leadership

Mr. Mi-Keun JungChief Executive Officer and President · b. 1954

Financials

Income Statement

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	48.16B	44.70B	50.21B	50.94B	53.28B	60.65B	61.44B	61.75B	80.01B	89.14B	89.44B	80.56B
Growth (%)	-	-7.18%	+12.32%	+1.45%	+4.58%	+13.84%	+1.30%	+0.51%	+29.56%	+11.41%	+0.34%	-9.92%
Cost of Revenue	23.94B	22.65B	26.36B	28.33B	32.39B	35.77B	37.23B	37.31B	44.36B	51.56B	48.77B	47.13B
Gross Profit	24.22B	22.06B	23.85B	22.61B	20.89B	24.88B	24.20B	24.44B	35.65B	37.57B	40.67B	33.44B
Gross Margin	50.29%	49.34%	47.49%	44.38%	39.20%	41.02%	39.40%	39.58%	44.55%	42.15%	45.47%	41.50%
Operating Expense	11.96B	11.62B	12.54B	13.63B	14.86B	15.48B	17.29B	16.44B	22.08B	23.59B	25.41B	26.05B
Operating Income	12.26B	10.43B	11.31B	8.98B	6.02B	9.40B	6.92B	8.00B	13.56B	13.98B	15.25B	7.39B
Operating Margin	25.46%	23.34%	22.53%	17.63%	11.30%	15.50%	11.26%	12.95%	16.95%	15.69%	17.05%	9.17%
EBITDA	-	-	-	-	-	-	-	-	19.08B	20.34B	22.17B	14.61B
EBITDA Margin	-	-	-	-	-	-	-	-	23.85%	22.82%	24.79%	18.13%
Net Income	10.18B	8.76B	10.04B	8.20B	5.71B	7.26B	7.54B	6.68B	12.16B	13.64B	14.30B	7.53B
Net Income Margin	21.14%	19.60%	19.99%	16.09%	10.72%	11.97%	12.28%	10.82%	15.20%	15.30%	15.99%	9.35%
R&D	56.67M	24.00M	63.85M	92.79M	852.62M	529.90M	784.55M	194.52M	3.26B	2.98B	2.80B	2.69B
R&D as % of Total Revenue	0.12%	0.05%	0.13%	0.18%	1.60%	0.87%	1.28%	0.31%	4.08%	3.34%	3.13%	3.34%
Interest Expense	0	0	0	0	0	0	13.24M	9.72M	6.05M	26.13M	26.97M	19.71M
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	0.02%	0.01%	0.03%	0.03%	0.02%

Balance Sheet

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	79.91B	87.26B	98.05B	102.52B	106.40B	117.84B	124.81B	128.97B	142.83B	152.46B	165.86B	169.49B
Total Liabilities	9.06B	9.09B	10.86B	11.59B	11.22B	16.59B	17.33B	15.78B	19.55B	17.56B	19.36B	17.14B
Total Equity	70.85B	78.17B	87.19B	90.93B	95.18B	101.24B	107.48B	113.20B	123.28B	134.90B	146.51B	152.35B
Cash	3.30B	2.03B	506.54M	2.24B	1.69B	2.95B	4.14B	29.87M	38.93M	7.52B	22.22M	9.31B
Total Debt	-	-	-	-	-	392.95M	267.01M	-	-	-	-	-

Cash Flow

Currency: KRW	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	9.33B	9.56B	12.09B	8.67B	9.19B	12.31B	11.06B	11.16B	13.69B	15.15B	22.69B	11.59B
Investing Cash Flow	-8.12B	-10.22B	-12.38B	-6.05B	-8.82B	-9.87B	-8.61B	-6.66B	-14.88B	-11.32B	-23.47B	-
Financing Cash Flow	-384.17M	-573.85M	-1.05B	-901.01M	-909.09M	-1.19B	-1.25B	-1.35B	-1.32B	-1.25B	-2.14B	-
Capital Expenditure	2.24B	5.80B	2.57B	9.38B	8.33B	9.73B	8.80B	3.63B	9.33B	12.92B	8.47B	4.45B
Free Cash Flow	-	-	-	-	-	8.63B	2.59B	7.53B	4.36B	2.23B	14.22B	7.13B
Dividends Paid	675.45M	900.60M	900.60M	1.05B	1.05B	1.05B	1.13B	1.05B	1.08B	1.11B	1.97B	2.20B
FCF to OCF	-	-	-	-	-	70.12%	23.42%	67.49%	31.85%	14.74%	62.68%	61.56%
Dividend Paid to FCF	-	-	-	-	-	12.18%	43.46%	13.94%	24.80%	49.80%	13.82%	30.79%

Earnings

Report Date	Mar 31, 2009	Jun 30, 2009	Sep 30, 2009	Dec 31, 2009	Mar 31, 2010	Jun 30, 2010	Sep 30, 2010	Dec 31, 2010	Mar 31, 2011	Jun 30, 2011	Sep 30, 2011	Dec 31, 2011	Mar 31, 2012	Jun 30, 2012	Sep 30, 2012	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Nov 10, 2014	Feb 5, 2015	May 18, 2015	Aug 18, 2015	Nov 17, 2015	Mar 15, 2016	Apr 28, 2016	Aug 8, 2016	Nov 3, 2016	Mar 7, 2017	May 15, 2017	Aug 14, 2017	Nov 14, 2017	Mar 19, 2018	May 15, 2018	Aug 14, 2018	Nov 14, 2018	Feb 25, 2019	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	77.67	134.12	50.17	62.52	85.35	116.17	56.43	82.98	63.43	51.73	64.56	88.68	99.77	120.12	74.53	88.68	133.65	166.31	208.33	123.47	189.97	232.13	224.50	231.47	195.84	202.57	181.39	176.15	226.35	222.85	188.28	353.00	192.52	171.80	136.70	157.85	174.45	145.55	2.98	152.35	108.01	210.84	142.58	164.57	173.56	215.61	167.31	94.33	82.95	122.01	149.73	222.04	217.09	304.87	212.42	316.49	328.61	146.70	300.05	404.71	316.84	342.03	239.71	338.54	174.38	240.06	225.55	11.50	124.25	193.97
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap74.91B

Enterprise Value30.05B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.86

Price / Book0.46

Revenue (TTM)86.82B

Gross Profit (TTM)37.03B

EBITDA12.07B

Profit Margin7.39%

Operating Margin9.34%

Return on Equity4.24%

Return on Assets2.13%

Shares Outstanding11.56M

Shares Float7.58M

Beta0.50

Dividend Yield2.95%

Dividend Rate190.00

Payout Ratio34.22%

Dividends

20251×

190.00Dec 29, 2025

20241×

190.00Dec 27, 2024

20231×

170.00Dec 27, 2023

20221×

100.00Dec 28, 2022

20211×

96.15Dec 29, 2021

20201×

93.35Dec 29, 2020

20191×

135.95Dec 27, 2019

20181×

90.63Dec 27, 2018

20171×

90.63Dec 27, 2017

20161×

90.63Dec 28, 2016

20151×

77.69Dec 29, 2015

20141×

77.69Dec 29, 2014

20131×

58.26Dec 27, 2013

20121×

51.79Dec 27, 2012

20111×

51.79Dec 28, 2011

20101×

51.79Dec 29, 2010

20091×

45.32Dec 29, 2009

20081×

45.32Dec 29, 2008

20071×

45.32Dec 27, 2007

20061×

45.32Dec 27, 2006

20051×

45.32Dec 28, 2005

20041×

38.84Dec 29, 2004

20031×

32.37Dec 29, 2003

20021×

25.90Dec 27, 2002

Stock Splits

Dec 28, 202226:25
Dec 29, 2021103:100
Dec 29, 2020103:100
Dec 27, 20197:5